Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Vaccines Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.3 Market by Application
1.3.1 Global HIV Vaccines Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Research Institute
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV Vaccines Market Perspective (2024-2034)
2.2 HIV Vaccines Growth Trends by Region
2.2.1 Global HIV Vaccines Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 HIV Vaccines Historic Market Size by Region (2024-2024)
2.2.3 HIV Vaccines Forecasted Market Size by Region (2024-2034)
2.3 HIV Vaccines Market Dynamics
2.3.1 HIV Vaccines Industry Trends
2.3.2 HIV Vaccines Market Drivers
2.3.3 HIV Vaccines Market Challenges
2.3.4 HIV Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Vaccines Players by Revenue
3.1.1 Global Top HIV Vaccines Players by Revenue (2024-2024)
3.1.2 Global HIV Vaccines Revenue Market Share by Players (2024-2024)
3.2 Global HIV Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV Vaccines Revenue
3.4 Global HIV Vaccines Market Concentration Ratio
3.4.1 Global HIV Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Vaccines Revenue in 2022
3.5 HIV Vaccines Key Players Head office and Area Served
3.6 Key Players HIV Vaccines Product Solution and Service
3.7 Date of Enter into HIV Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Vaccines Breakdown Data by Type
4.1 Global HIV Vaccines Historic Market Size by Type (2024-2024)
4.2 Global HIV Vaccines Forecasted Market Size by Type (2024-2034)
5 HIV Vaccines Breakdown Data by Application
5.1 Global HIV Vaccines Historic Market Size by Application (2024-2024)
5.2 Global HIV Vaccines Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America HIV Vaccines Market Size (2024-2034)
6.2 North America HIV Vaccines Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America HIV Vaccines Market Size by Country (2024-2024)
6.4 North America HIV Vaccines Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV Vaccines Market Size (2024-2034)
7.2 Europe HIV Vaccines Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe HIV Vaccines Market Size by Country (2024-2024)
7.4 Europe HIV Vaccines Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV Vaccines Market Size (2024-2034)
8.2 Asia-Pacific HIV Vaccines Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific HIV Vaccines Market Size by Region (2024-2024)
8.4 Asia-Pacific HIV Vaccines Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV Vaccines Market Size (2024-2034)
9.2 Latin America HIV Vaccines Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America HIV Vaccines Market Size by Country (2024-2024)
9.4 Latin America HIV Vaccines Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Vaccines Market Size (2024-2034)
10.2 Middle East & Africa HIV Vaccines Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa HIV Vaccines Market Size by Country (2024-2024)
10.4 Middle East & Africa HIV Vaccines Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Argos Therapeutics
11.1.1 Argos Therapeutics Company Detail
11.1.2 Argos Therapeutics Business Overview
11.1.3 Argos Therapeutics HIV Vaccines Introduction
11.1.4 Argos Therapeutics Revenue in HIV Vaccines Business (2024-2024)
11.1.5 Argos Therapeutics Recent Development
11.2 Bionor Pharma
11.2.1 Bionor Pharma Company Detail
11.2.2 Bionor Pharma Business Overview
11.2.3 Bionor Pharma HIV Vaccines Introduction
11.2.4 Bionor Pharma Revenue in HIV Vaccines Business (2024-2024)
11.2.5 Bionor Pharma Recent Development
11.3 Janssen Global Services
11.3.1 Janssen Global Services Company Detail
11.3.2 Janssen Global Services Business Overview
11.3.3 Janssen Global Services HIV Vaccines Introduction
11.3.4 Janssen Global Services Revenue in HIV Vaccines Business (2024-2024)
11.3.5 Janssen Global Services Recent Development
11.4 Genecure
11.4.1 Genecure Company Detail
11.4.2 Genecure Business Overview
11.4.3 Genecure HIV Vaccines Introduction
11.4.4 Genecure Revenue in HIV Vaccines Business (2024-2024)
11.4.5 Genecure Recent Development
11.5 Geovax
11.5.1 Geovax Company Detail
11.5.2 Geovax Business Overview
11.5.3 Geovax HIV Vaccines Introduction
11.5.4 Geovax Revenue in HIV Vaccines Business (2024-2024)
11.5.5 Geovax Recent Development
11.6 Paxvax
11.6.1 Paxvax Company Detail
11.6.2 Paxvax Business Overview
11.6.3 Paxvax HIV Vaccines Introduction
11.6.4 Paxvax Revenue in HIV Vaccines Business (2024-2024)
11.6.5 Paxvax Recent Development
11.7 Inovio Pharmaceuticals
11.7.1 Inovio Pharmaceuticals Company Detail
11.7.2 Inovio Pharmaceuticals Business Overview
11.7.3 Inovio Pharmaceuticals HIV Vaccines Introduction
11.7.4 Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2024-2024)
11.7.5 Inovio Pharmaceuticals Recent Development
11.8 Glaxosmithkline
11.8.1 Glaxosmithkline Company Detail
11.8.2 Glaxosmithkline Business Overview
11.8.3 Glaxosmithkline HIV Vaccines Introduction
11.8.4 Glaxosmithkline Revenue in HIV Vaccines Business (2024-2024)
11.8.5 Glaxosmithkline Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi HIV Vaccines Introduction
11.9.4 Sanofi Revenue in HIV Vaccines Business (2024-2024)
11.9.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global HIV Vaccines Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Global HIV Vaccines Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global HIV Vaccines Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 7. Global HIV Vaccines Market Size by Region (2024-2024) & (US$ Million)
Table 8. Global HIV Vaccines Market Share by Region (2024-2024)
Table 9. Global HIV Vaccines Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global HIV Vaccines Market Share by Region (2024-2034)
Table 11. HIV Vaccines Market Trends
Table 12. HIV Vaccines Market Drivers
Table 13. HIV Vaccines Market Challenges
Table 14. HIV Vaccines Market Restraints
Table 15. Global HIV Vaccines Revenue by Players (2024-2024) & (US$ Million)
Table 16. Global HIV Vaccines Market Share by Players (2024-2024)
Table 17. Global Top HIV Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Vaccines as of 2022)
Table 18. Ranking of Global Top HIV Vaccines Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by HIV Vaccines Revenue (CR5 and HHI) & (2024-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players HIV Vaccines Product Solution and Service
Table 22. Date of Enter into HIV Vaccines Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global HIV Vaccines Market Size by Type (2024-2024) & (US$ Million)
Table 25. Global HIV Vaccines Revenue Market Share by Type (2024-2024)
Table 26. Global HIV Vaccines Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global HIV Vaccines Revenue Market Share by Type (2024-2034)
Table 28. Global HIV Vaccines Market Size by Application (2024-2024) & (US$ Million)
Table 29. Global HIV Vaccines Revenue Market Share by Application (2024-2024)
Table 30. Global HIV Vaccines Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global HIV Vaccines Revenue Market Share by Application (2024-2034)
Table 32. North America HIV Vaccines Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 33. North America HIV Vaccines Market Size by Country (2024-2024) & (US$ Million)
Table 34. North America HIV Vaccines Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe HIV Vaccines Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 36. Europe HIV Vaccines Market Size by Country (2024-2024) & (US$ Million)
Table 37. Europe HIV Vaccines Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific HIV Vaccines Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Asia-Pacific HIV Vaccines Market Size by Region (2024-2024) & (US$ Million)
Table 40. Asia-Pacific HIV Vaccines Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America HIV Vaccines Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 42. Latin America HIV Vaccines Market Size by Country (2024-2024) & (US$ Million)
Table 43. Latin America HIV Vaccines Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa HIV Vaccines Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 45. Middle East & Africa HIV Vaccines Market Size by Country (2024-2024) & (US$ Million)
Table 46. Middle East & Africa HIV Vaccines Market Size by Country (2024-2034) & (US$ Million)
Table 47. Argos Therapeutics Company Detail
Table 48. Argos Therapeutics Business Overview
Table 49. Argos Therapeutics HIV Vaccines Product
Table 50. Argos Therapeutics Revenue in HIV Vaccines Business (2024-2024) & (US$ Million)
Table 51. Argos Therapeutics Recent Development
Table 52. Bionor Pharma Company Detail
Table 53. Bionor Pharma Business Overview
Table 54. Bionor Pharma HIV Vaccines Product
Table 55. Bionor Pharma Revenue in HIV Vaccines Business (2024-2024) & (US$ Million)
Table 56. Bionor Pharma Recent Development
Table 57. Janssen Global Services Company Detail
Table 58. Janssen Global Services Business Overview
Table 59. Janssen Global Services HIV Vaccines Product
Table 60. Janssen Global Services Revenue in HIV Vaccines Business (2024-2024) & (US$ Million)
Table 61. Janssen Global Services Recent Development
Table 62. Genecure Company Detail
Table 63. Genecure Business Overview
Table 64. Genecure HIV Vaccines Product
Table 65. Genecure Revenue in HIV Vaccines Business (2024-2024) & (US$ Million)
Table 66. Genecure Recent Development
Table 67. Geovax Company Detail
Table 68. Geovax Business Overview
Table 69. Geovax HIV Vaccines Product
Table 70. Geovax Revenue in HIV Vaccines Business (2024-2024) & (US$ Million)
Table 71. Geovax Recent Development
Table 72. Paxvax Company Detail
Table 73. Paxvax Business Overview
Table 74. Paxvax HIV Vaccines Product
Table 75. Paxvax Revenue in HIV Vaccines Business (2024-2024) & (US$ Million)
Table 76. Paxvax Recent Development
Table 77. Inovio Pharmaceuticals Company Detail
Table 78. Inovio Pharmaceuticals Business Overview
Table 79. Inovio Pharmaceuticals HIV Vaccines Product
Table 80. Inovio Pharmaceuticals Revenue in HIV Vaccines Business (2024-2024) & (US$ Million)
Table 81. Inovio Pharmaceuticals Recent Development
Table 82. Glaxosmithkline Company Detail
Table 83. Glaxosmithkline Business Overview
Table 84. Glaxosmithkline HIV Vaccines Product
Table 85. Glaxosmithkline Revenue in HIV Vaccines Business (2024-2024) & (US$ Million)
Table 86. Glaxosmithkline Recent Development
Table 87. Sanofi Company Detail
Table 88. Sanofi Business Overview
Table 89. Sanofi HIV Vaccines Product
Table 90. Sanofi Revenue in HIV Vaccines Business (2024-2024) & (US$ Million)
Table 91. Sanofi Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Vaccines Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global HIV Vaccines Market Share by Type: 2022 VS 2034
Figure 3. Phase I Features
Figure 4. Phase II Features
Figure 5. Phase III Features
Figure 6. Global HIV Vaccines Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global HIV Vaccines Market Share by Application: 2022 VS 2034
Figure 8. Research Institute Case Studies
Figure 9. Others Case Studies
Figure 10. HIV Vaccines Report Years Considered
Figure 11. Global HIV Vaccines Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 12. Global HIV Vaccines Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global HIV Vaccines Market Share by Region: 2022 VS 2034
Figure 14. Global HIV Vaccines Market Share by Players in 2022
Figure 15. Global Top HIV Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Vaccines as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by HIV Vaccines Revenue in 2022
Figure 17. North America HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 18. North America HIV Vaccines Market Share by Country (2024-2034)
Figure 19. United States HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. Canada HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. Europe HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Europe HIV Vaccines Market Share by Country (2024-2034)
Figure 23. Germany HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. France HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. U.K. HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. Italy HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. Russia HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Nordic Countries HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Asia-Pacific HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Asia-Pacific HIV Vaccines Market Share by Region (2024-2034)
Figure 31. China HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Japan HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. South Korea HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Southeast Asia HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. India HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Australia HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Latin America HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Latin America HIV Vaccines Market Share by Country (2024-2034)
Figure 39. Mexico HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Brazil HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Middle East & Africa HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Middle East & Africa HIV Vaccines Market Share by Country (2024-2034)
Figure 43. Turkey HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Saudi Arabia HIV Vaccines Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Argos Therapeutics Revenue Growth Rate in HIV Vaccines Business (2024-2024)
Figure 46. Bionor Pharma Revenue Growth Rate in HIV Vaccines Business (2024-2024)
Figure 47. Janssen Global Services Revenue Growth Rate in HIV Vaccines Business (2024-2024)
Figure 48. Genecure Revenue Growth Rate in HIV Vaccines Business (2024-2024)
Figure 49. Geovax Revenue Growth Rate in HIV Vaccines Business (2024-2024)
Figure 50. Paxvax Revenue Growth Rate in HIV Vaccines Business (2024-2024)
Figure 51. Inovio Pharmaceuticals Revenue Growth Rate in HIV Vaccines Business (2024-2024)
Figure 52. Glaxosmithkline Revenue Growth Rate in HIV Vaccines Business (2024-2024)
Figure 53. Sanofi Revenue Growth Rate in HIV Vaccines Business (2024-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed